ID
24054
Description
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00469092
Link
https://clinicaltrials.gov/show/NCT00469092
Keywords
Versions (1)
- 7/24/17 7/24/17 -
Uploaded on
July 24, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes NCT00469092
Eligibility Diabetes NCT00469092
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Medical contraindication Metformin
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0025598
Description
Thiazolidinediones
Data type
boolean
Alias
- UMLS CUI [1]
- C1257987
Description
Systemic Corticosteroid Therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C4053960
Description
Disease Interferes with Clinical Trial | Condition Interferes with Clinical Trial
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C0521102
- UMLS CUI [1,3]
- C0008976
- UMLS CUI [2,1]
- C0348080
- UMLS CUI [2,2]
- C0521102
- UMLS CUI [2,3]
- C0008976
Similar models
Eligibility Diabetes NCT00469092
- StudyEvent: Eligibility
C1527415 (UMLS CUI [1,2])
C0021641 (UMLS CUI [1,2])
C1283071 (UMLS CUI [1,3])
C0178602 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0919936 (UMLS CUI [1,2])
C0025598 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])